Mature DCs not only activate CTLs to target tumors but are also capable of activating NK cells by enhancing their cytotoxicity, IFN-γ production, and the crosstalk of NK cells; DCs also play an important role in the induction of the tumor-specific immune response against cancer (32, 33). This evidence concerns the gene IFNG and cancer.